Get all premium features to the best stock analysis tool

Finranks

Finranks

Company

  • About us

Contact us

  • [email protected]

Follow us

  • Instagram
  • Telegram
  • LinkedIn

All rights reserved.

Privacy PolicyTerms of Conditions
  • Home
  • Markets
  • Screener
  • News
  • About
  1. Home
  2. PEN
P

Penumbra, Inc. (PEN)

335.10

0.00 (0.00%)

  • Summary
  • News
  • Chart
  • Financial
  • Dividends
  • Forecast
  • Ownership
  • Profile

Penumbra, Inc.

CountryUnited States
IndustryMedical Devices
SectorHealthcare
IPO Date2015-09-18
CEOAdam Elsesser

About the company

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Key Executives

NamePosition
Dr. Arani Bose M.D.Co-Founder & Director
Mr. Adam Elsesser J.D.Co-Founder, Chairman & CEO
Mr. Ben SorciExecutive Vice President of Operations
Mr. Ben TompkinsExecutive Vice President of Development & Compliance
Mr. Lambert ShiuChief Accounting Officer
Mr. Pankaj TiwariExecutive VP & Chief Information Officer
Ms. Jee Hamlyn-HarrisInvestor Relations Officer
Ms. Johanna Roberts J.D.Executive VP, General Counsel & Secretary
Ms. Maggie S. YuenChief Financial Officer
Ms. Shruthi NarayanPresident

Penumbra, Inc.

CountryUnited States
IndustryMedical Devices
SectorHealthcare
IPO Date2015-09-18
CEOAdam Elsesser

Contact Details

Address:One Penumbra Place, Alameda, California 94502, United States
Phone:510 748 3200
Website:https://www.penumbrainc.com

Stock Details

Ticker Symbol:PEN
Exchange:NYSE
Fiscal Year:January - December
Reporting Currency:USD
CIK Code:0001321732
CUSIP Number:70975L107
ISIN Number:US70975L1070
SIC Code:3841

Latest SEC Filings

DateTypeDocument
2026-01-16425dp240103_425.htm
2026-01-15425dp240020_425.htm
2025-11-0510-Qpen-20250930.htm
2025-08-278-Kpen-20250822.htm
2025-07-2910-Qpen-20250630.htm
2025-05-308-Kpen-20250528.htm
2025-04-2310-Qpen-20250331.htm
2025-04-16DEFA14Apenumbrainc2025defa14a.htm
2025-04-04PRE 14Apen-20250403.htm
2025-02-218-Kpen-20250214.htm